Skip to main content
Ono Pharmaceutical Co., Ltd. (OPHLF)
OTCMKTS · Delayed Price · Currency is USD
10.73
0.00 (0.00%)
May 14, 2025, 4:00 PM EDT

Ono Pharmaceutical Revenue

In the fiscal year ending March 31, 2025, Ono Pharmaceutical had annual revenue of 486.87B JPY, down -3.14%. Ono Pharmaceutical had revenue of 112.31B in the quarter ending March 31, 2025, a decrease of -0.41%.

Revenue
486.87B JPY
Revenue Growth
-3.14%
P/S Ratio
1.48
Revenue / Employee
126.36M JPY
Employees
3,853
Market Cap
4.81B USD

Revenue Chart

* This company reports financials in JPY.

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025486.87B-15.80B-3.14%
Mar 31, 2024502.67B55.49B12.41%
Mar 31, 2023447.19B85.83B23.75%
Mar 31, 2022361.36B52.08B16.84%
Mar 31, 2021309.28B16.86B5.77%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.73B
Veradigm 588.02M
Tian'an Technology Group 1.78M
Glass House Brands 215.62M
Elite Pharmaceuticals 70.00M
Northwest Biotherapeutics 1.38M
BioStem Technologies 301.83M
Silence Therapeutics 27.70M
Revenue Rankings

Ono Pharmaceutical News

More News